Article Details

Eiger BioPharmaceuticals (NASDAQ:EIGR) Rating Lowered to Sell at StockNews.com

Retrieved on: 2022-09-09 17:23:48

Tags for this article:

Click the tags to see associated articles and topics

Eiger BioPharmaceuticals (NASDAQ:EIGR) Rating Lowered to Sell at StockNews.com. View article details on hiswai:

Excerpt

Eiger BioPharmaceuticals has a 12-month low of $3.53 and a 12-month high of $10.02. The stock has a market cap of $288.42 million, a price-to-earnings ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up